Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Management of hepatocellular carcinoma.

Journal of cancer research and clinical oncology·2014

Same author

Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma.

Alimentary pharmacology & therapeutics·2010

Same author

Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients.

Alimentary pharmacology & therapeutics·2008

Same author

Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin*.

Journal of viral hepatitis·2006

Same author

Drug treatment of the complications of cirrhosis in the older adult.

Drugs & aging·2001

Same author

Risk Factors for Candida tropicalis fungemia in patients with cancer.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001

Search research articles

Related Experiment Video

Updated: May 11, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Alcohol has no effect on hepatitis C virus replication: a meta-analysis.

B S Anand¹, J Thornby

¹Department of Medicine, Michael E DeBakey VA Medical Center and Baylor College of Medicine, Houston, TX 77030, USA. ana0@flash.net

|September 16, 2005

Summary

This meta-analysis found no link between alcohol consumption and hepatitis C virus (HCV) levels. Alcohol and HCV may cause liver damage through separate mechanisms, rather than alcohol increasing viral replication.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

Related Experiment Videos

Last Updated: May 11, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

A Protocol for Analyzing Hepatitis C Virus Replication

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

Area of Science:

Hepatology
Virology
Addiction Medicine

Background:

Chronic hepatitis C virus (HCV) infection leads to more severe liver disease in heavy alcohol consumers.
The exact mechanism by which alcohol exacerbates HCV-related liver damage is not fully understood.
A potential mechanism is alcohol's stimulation of HCV replication.

Purpose of the Study:

To investigate the association between alcohol consumption and hepatitis C virus (HCV) replication.
To determine if alcohol intake influences HCV viral load in patients.
To clarify the interplay between alcohol use and HCV pathogenesis.

Main Methods:

A meta-analysis of 14 identified studies.
Comparison of viral loads between heaviest drinkers and non-drinkers.
Assessment of alcohol's effect using graded doses and examining abstinence.

Main Results:

The overall meta-analysis showed no significant association between alcohol consumption and HCV viral levels (p = 0.29).
Analysis of graded alcohol doses also revealed no significant differences in viral load across non-drinkers, moderate, and heavy drinkers.
Five studies on abstinence lacked sufficient data for statistical analysis.

Conclusions:

This study did not find evidence supporting a link between alcohol use and HCV viral titres.
The findings suggest that alcohol and HCV may cause additive hepatic damage via independent mechanisms.
Further research may be needed to elucidate the specific pathways involved in alcohol-induced liver injury in HCV patients.